[Skip to Content]
[Skip to Content Landing]
November 20, 2013

Need for Increased Awareness and Evidence-Based Therapies for Patients Hospitalized for Heart Failure

Author Affiliations
  • 1Division of Cardiology, Emory University, Atlanta, Georgia
  • 2Division of Cardiology, University of California Los Angeles
  • 3Center for Cardiovascular Innovation, Northwestern Feinberg School of Medicine, Chicago, Illinois
JAMA. 2013;310(19):2035-2036. doi:10.1001/jama.2013.282815

There remains a substantial and widening gap between the epidemiologic, clinical, and socioeconomic importance of heart failure hospitalizations and the lack of therapeutic progress made over the last few decades. Heart failure is the primary cause of more than one million US hospitalizations annually and is a contributory diagnosis in an additional 2 million to 3 million hospitalizations.1 These figures are projected to increase with the aging population. The cardiovascular mortality and readmission rate for patients recently discharged following an admission for heart failure is approximately 25% at 6 months, and all-cause mortality exceeds 30% at 1 year. These figures have remained largely unchanged over the last 2 decades.2,3